glp 1 retinopathy GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know January Blog - GLP1s and
Description
May improve insulin sensitivity
The starting dose is typically 0.25 mg once weekly, which over time can be steadily increased
Someone with a blunted receptor may need a more tailored, personalised approach
Hepatology 51:158492
Obesity, particularly in those with android body fat distribution, are at increased risk of NAFLD and disease progression and individuals with complications such as hypertension, knee osteoarthritis, or sleep apnea should also be screened for advanced liver disease
Metformin controversies and risks Does it work for healthy people
